Is Ritonavir-Boosted Atazanavir a Risk for Cholelithiasis Compared to Other Protease Inhibitors?

OBJECTIVE: To compare the incidence of complicated cholelithiasis in patients receiving ritonavir-boosted atazanavir (ATV/r)- containing antiretroviral therapy with those on other protease inhibitors (PIs). DESIGN: We conducted a single-center retrospective cohort study of patients who started eithe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hamada, Yohei, Nishijima, Takeshi, Komatsu, Hirokazu, Teruya, Katsuji, Gatanaga, Hiroyuki, Kikuchi, Yoshimi, Oka, Shinichi
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3713059/
https://ncbi.nlm.nih.gov/pubmed/23875004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0069845
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados